Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients

dc.contributor.author	Orcen, Arda
dc.contributor.author	Kucukerden, Melike
dc.contributor.author	Yetimler, Berrak
dc.contributor.author	Ulusoy, Canan Aysel
dc.contributor.author	Tuzun, Erdem
dc.contributor.author	Turan, Selin
dc.contributor.author	Akbas-demir, Deniz
dc.contributor.author	Turkoglu, Recai
dc.contributor.author	Haytural, Hazal
dc.date.accessioned	2021-03-05T16:36:58Z
dc.date.available	2021-03-05T16:36:58Z
dc.identifier.citation	Tuzun E., Ulusoy C. A. , Turan S., Orcen A., Yetimler B., Akbas-demir D., Kucukerden M., Haytural H., Turkoglu R., "Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients", 12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.228
dc.identifier.other	vv_1032021
dc.identifier.other	av_c1838512-2c72-4aab-9ce0-da3289816693
dc.identifier.uri	http://hdl.handle.net/20.500.12627/128431
dc.identifier.uri	https://doi.org/10.1016/j.jneuroim.2014.08.610
dc.language.iso	eng
dc.subject	Temel Bilimler
dc.subject	İmmünoloji
dc.subject	NEUROSCIENCES
dc.subject	Sinirbilim ve Davranış
dc.subject	Yaşam Bilimleri
dc.subject	Yaşam Bilimleri (LIFE)
dc.title	Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients
dc.type	Bildiri
dc.contributor.department	Istanbul Haydarpasa Numune Training & Research Hospital , ,
dc.identifier.volume	275
dc.contributor.firstauthorID	145265

Files in this item

Files	Size	Format	View
There are no files associated with this item.